September: Nevro earned FDA approval and began a limited market release of its HFX iQ spinal cord stimulator with HFX AdaptivAI. October: Allied Market Research forecasts the spinal cord stimulator ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

Multiple sclerosis causes lesions to the spinal cord and other parts of the central nervous system. An MRI can detect spinal cord lesions and help diagnose and monitor the condition. Multiple ...

Spinal Cord is a specialised, international journal that has been publishing spinal cord related manuscripts since 1963. It appears monthly, online and in print, and accepts contributions on ...

5. Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company. Globus Medical’s transaction will include all shares of Nevro, which are valued at about $250 million. The deal is slated ...

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

Nevro NVRO is well-poised for growth in the ... However, concerns regarding softness in the spinal cord stimulation (SCS) market and dependence on third-party payers persist.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medically reviewed by Eva Umoh Asomugha, M.D. Myelopathy refers to a cluster of symptoms that result from spinal cord compression. This can occur from trauma, inflammation, tumors, or the ...